Table 3
Rejection, treatment failure, adverse events
| CSA | MMF | |
|---|---|---|
| Rejection | ||
| In the first 6 postoperative months | 1 (5%) | 1 (4.5%) |
| After cessation of immunosuppressive therapy | 1 (5%) | 1 (4.5%) |
| Irreversible graft failure from rejection | 0 | 0 |
| Premature withdrawal | 1 (5%) | 2 (9.1%) |
| Hepatotoxicity | 1 (5%) | 0 |
| Hodgkin’s lymphoma | 0 | 1 (4.5%) |
| Unsatisfactory therapeutic response | 0 | 1 (4.5%) |
-
↵The rejection episodes involved different grafts, no graft was rejected twice.
